EVX-01

N/A

Report date: 2024/01/02 20:03:52

Base Information

Drug NameEVX-01
Drug Alias NameNeoPepVacNPV-ds001NPV-ds001-CAF09bEVX-01EVAX-01-CAF09b
ClassificationVaccines > Application > Therapeutic vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsCarcinoma, Non-Small-Cell LungCarcinoma, Transitional CellMelanoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryItalyDenmarkAustralia
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesEvaxion Biotech A/S
China Registration ClassN/A

Develop Information

Active CompaniesEvaxion Biotech A/SMerck Sharp & Dohme LLC
Inactive CompaniesHerlev Hospital
Active IndicationsMelanoma
Inactive IndicationsCarcinoma, Non-Small-Cell LungCarcinoma, Transitional Cell

Other Information

ATC CodeN/A
Related LinksN/A